Table 2.
A Multivariate Analysis of Factors that might have been Related to NeP in the Patients of the Present Study.
| Model 1 | Model 2 | ||||||
|---|---|---|---|---|---|---|---|
| Odds ratio | 95% CI | p value | Odds ratio | 95% CI | p value | ||
| DAS28-ESR non CR vs. CR (reference) | 3.40 | 1.34-8.64 | 0.0101 | 3.87 | 1.76-8.51 | <0.001 | |
| BMI≥22 vs. others (reference) | 2.68 | 1.26-5.69 | 0.0101 | 2.48 | 1.129-5.17 | 0.0150 | |
| Underlying disease + vs. – (reference) | 0.999 | 0.462-2.16 | 0.997 | 1.040 | 0.502-2.16 | 0.914 | |
| Age | 0.989 | 0.964-1.01 | 0.392 | ||||
| Pain VAS | 1.010 | 0.993-1.03 | 0.220 | ||||
| CRP<0.6 mg/dL | 0.414 | 0.156-1.10 | 0.077 | ||||
| ESR | 0.982 | 0.958-1.01 | 0.154 | ||||
| Male gender | 0.761 | 0.328-1.77 | 0.526 | ||||
CI: confidential interval, DAS28-ESR: disease activity score-28 based on erythrocyte sedimentation rate, CR: clinical remission, PSL: prednisolon, BMI; body mass index, VAS: visual analogue scale, CRP: C-reactive protein, ESR: erythrocyte sedimentation rate